Authors


Michael Joyner, MD

Latest:

COVID-19 Convalescent Plasma: What Is Its Role in Therapy?

The key is using the right dose on the right patient at the right time.


Sara Groome, PharmD, BCIDP

Latest:

Restoring Hope by Restoring Gut Flora: Rebyota and the Future of Combating Recurrent CDI

Although fecal microbiota, live-jslm (Rebyota; RBX2660) is the first fecal microbiota product approved by the FDA, there are other microbiota-based agents in the pipeline.


Angela Rasmussen, PhD

Latest:

COVID-19 Booster Shots and the Future

Key opinion leaders provide some advice for the public regarding COVID-19 booster shots and look to the future of the pandemic.


Keith Lee

Latest:

Final Diagnosis: Pott Puffy Tumor With Subdural Empyema

A rare case of Pott puffy tumor occurs in an atypical patient with no risk factors, likely due to untreated sinus infection.


Seth Lederman, MD

Latest:

Our Price for Not Aiming Higher: Long COVID Is Here to Stay

Guest author Seth Lederman, MD, calls Long COVID "one of the most pressing global health threats I have seen since fighting HIV/AIDS."


Marco Meglio

Latest:

Positive Impact of Antiviral Therapy in Multiple Sclerosis

In a case report, a patient with HIV with active multiple sclerosis showed reduced disease activity with tenofovir-containing antiretrovirals, suggesting potential MS treatment benefits.


Tristan Timbrook PharmD, MBA, BCPS

Latest:

Lifting the Medical and Economic Burden of AMR in the US

This bipartisan initiative highlights the need for a comprehensive approach to combat antimicrobial resistance (AMR), incorporating both antibiotic drug development and increased funding for stewardship programs.


Laya Manoj

Latest:

Disseminated Gonococcal Infection Complicated by Suspected Osteomyelitis of Humeral Head

Gonococcal septic polyarthritis is an uncommon manifestation of N gonorrhoeae infection, but has increased by about 40% in recent years.


Randi Silibovsky, MD

Latest:

Community-Acquired Candida Glabrata Empyema: An Atypical Diagnosis Not to Miss

Although this patient had none of these common risk factors associated with Candida empyema, she did have other factors predisposing her to fungal colonization and subsequent infection.


Rebecca O’Toole

Latest:

Amoxicillin Treatment for Syphilis: Can an Old Drug Learn a New Trick?

With an increased incidence of this sexually transmitted infection, a review of an older antibiotic for treatment has shown some clinical benefits in other countries.


Fidelia Bernice, PharmD, BCIDP

Latest:

Daptomycin as Frontline Therapy for MRSA Bacteremia: Has the Time Come?

Findings increasingly suggest the mortality risk may be reduced by initiating daptomycin within 3 days of infection.


Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP

Latest:

Practice Pearls for Treatment of Respiratory Infections

Tina Tan, MD; Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP; Priya Nori, MD; Jacinda Abdul-Mutakabbir, PharmD; and Kevin Michael Reiter, MD, PA, provide key takeaways from the discussion on the treatment of respiratory viral infections.


Leanna Liu, PharmD, BCIDP, BCPS

Latest:

Amped-up Enterobacterales Debate

Demystifying clinical data for treating invasive AmpC-harboring Enterobacterales.


Mina Seo

Latest:

Impact of Inpatient Pharmacist Review of Discharge Antibiotics

A food for thought as an ambulatory antibiotic stewardship initiative.


Amy L. Brotherton, PharmD, AAHIVP, BCIDP

Latest:

Ready, Set, Cabenuva: Implementing Cabotegravir/Rilpivirine

This novel therapeutic option represents the first long-acting injectable approved for maintenance of HIV-1 suppression.


Sarah B. Minor, PharmD, MHA, BCPS-AQ ID

Latest:

The Next Generation of COVID-19 Vaccines and Boosters

Will there be an answer to keep the continuously evolving virus at bay? Are seasonal combination vaccines the wave of the future?


Chelsie Derman

Latest:

Hepatitis B Vaccination Increases Survival of Patients with Chronic Liver Disease

Hepatitis B virus vaccination shown to to significantly improve survival rates for patients with chronic hepatitis C, nonalcoholic liver disease, and liver cirrhosis.


Megan E. Uehling, MD

Latest:

Barriers to Health Care Transition in Adolescents and Young Adults With Early Acquired HIV Infection

Unique challenges can affect the success of the shift from pediatric to adult care settings.


Sahil Khanna, MBBS, MS

Latest:

Looking Toward the Future of CDI Management

Closing out their discussion on Clostridioides difficile infection, panelists share closing thoughts on novel pipeline therapies.


Aaron Hamby, PharmD

Latest:

Unmasking the Infodemic: The Impact of COVID-19 Misinformation on Public Health

Social media platforms, public health agencies, and communities must join forces to stop the rapid spread of false information.


Cheryl Wood, PharmD

Latest:

New Fecal Microbiota Options for Prevention of Recurrent Clostridioides difficile

With the addition of 2 new live biotherapeutic products, a clinician reviews the application, storage and administration techniques for them.


Louise-Marie Oleksiuk, PharmD, BCPS

Latest:

Daptomycin as Frontline Therapy for MRSA Bacteremia: Has the Time Come?

Findings increasingly suggest the mortality risk may be reduced by initiating daptomycin within 3 days of infection.


Mehrnaz Sadrolashrafi, PharmD, BCCCP

Latest:

COVID-19–Associated Fungal Infections During EMCO: Review of Epidemiology, Diagnosis, and Pharmacotherapy

Examining pharmacological management in COVID-19 patients with ARDS requiring antifungal therapy during extracorporeal life support.


Zachary Hitchcock, PharmD Candidate; and J. Drew Zimmer, PharmD, BCPS, *SIDP

Latest:

Getting Help from HAL: Applying Machine Learning to Predict Antibiotic Resistance

A pair of experts assess literature on the means of interpreting hospitalized patient antibiotic resistance through machine learning.


Abigail Geyer, PharmD

Latest:

Emergency Department Antimicrobial Stewardship: A Critical Area of Focus for Health Systems

As the first line of acute care, emergency departments are key stewards of antibiotics.


Gregory P. Monohan, MD

Latest:

Sorry Ganciclovir, You’re Just Not the One for Me

Important clinical considerations to know about resistant CMV infections.




Lacy Worden, PharmD, BCIDP

Latest:

Emergency Department Antimicrobial Stewardship: A Critical Area of Focus for Health Systems

As the first line of acute care, emergency departments are key stewards of antibiotics.


Jason Hedvat, PharmD, BCIDP

Latest:

To Prophylax or not to Prophylax: Preventing CDI

Clinicians look at optimal approaches for trying to avoid Clostridioides difficile infection (CDI).

© 2024 MJH Life Sciences

All rights reserved.